nodes	percent_of_prediction	percent_of_DWPC	metapath
Penbutolol—HTR1B—trigeminal nucleus—multiple sclerosis	0.292	0.595	CbGeAlD
Penbutolol—HTR1B—trigeminal nerve—multiple sclerosis	0.0766	0.156	CbGeAlD
Penbutolol—Atrioventricular block—Fingolimod—multiple sclerosis	0.0177	0.0427	CcSEcCtD
Penbutolol—Rash erythematous—Cladribine—multiple sclerosis	0.0127	0.0306	CcSEcCtD
Penbutolol—HTR1B—brainstem—multiple sclerosis	0.012	0.0245	CbGeAlD
Penbutolol—Arterial thrombosis—Methotrexate—multiple sclerosis	0.0118	0.0285	CcSEcCtD
Penbutolol—HTR1A—brainstem—multiple sclerosis	0.00969	0.0198	CbGeAlD
Penbutolol—Depression—Fingolimod—multiple sclerosis	0.00958	0.0231	CcSEcCtD
Penbutolol—Bradycardia—Fingolimod—multiple sclerosis	0.00878	0.0212	CcSEcCtD
Penbutolol—ORM1—spinal cord—multiple sclerosis	0.00796	0.0162	CbGeAlD
Penbutolol—Disorientation—Cladribine—multiple sclerosis	0.0079	0.019	CcSEcCtD
Penbutolol—HTR1B—midbrain—multiple sclerosis	0.00765	0.0156	CbGeAlD
Penbutolol—Alopecia—Fingolimod—multiple sclerosis	0.00762	0.0184	CcSEcCtD
Penbutolol—HTR1B—spinal cord—multiple sclerosis	0.00747	0.0152	CbGeAlD
Penbutolol—ORM1—nervous system—multiple sclerosis	0.00671	0.0137	CbGeAlD
Penbutolol—Throat sore—Triamcinolone—multiple sclerosis	0.0067	0.0161	CcSEcCtD
Penbutolol—Oropharyngeal discomfort—Triamcinolone—multiple sclerosis	0.00664	0.016	CcSEcCtD
Penbutolol—Cough—Fingolimod—multiple sclerosis	0.00655	0.0158	CcSEcCtD
Penbutolol—ORM1—central nervous system—multiple sclerosis	0.00646	0.0132	CbGeAlD
Penbutolol—HTR1B—nervous system—multiple sclerosis	0.00629	0.0128	CbGeAlD
Penbutolol—HTR1A—midbrain—multiple sclerosis	0.00618	0.0126	CbGeAlD
Penbutolol—HTR1B—central nervous system—multiple sclerosis	0.00606	0.0124	CbGeAlD
Penbutolol—HTR1A—spinal cord—multiple sclerosis	0.00602	0.0123	CbGeAlD
Penbutolol—ADRB1—nervous system—multiple sclerosis	0.00592	0.0121	CbGeAlD
Penbutolol—Rash erythematous—Betamethasone—multiple sclerosis	0.00572	0.0138	CcSEcCtD
Penbutolol—Rash erythematous—Dexamethasone—multiple sclerosis	0.00572	0.0138	CcSEcCtD
Penbutolol—ADRB1—central nervous system—multiple sclerosis	0.0057	0.0116	CbGeAlD
Penbutolol—Upper respiratory tract infection—Cladribine—multiple sclerosis	0.00568	0.0137	CcSEcCtD
Penbutolol—Dyspnoea—Fingolimod—multiple sclerosis	0.00547	0.0132	CcSEcCtD
Penbutolol—Oropharyngeal pain—Triamcinolone—multiple sclerosis	0.00531	0.0128	CcSEcCtD
Penbutolol—Fatigue—Fingolimod—multiple sclerosis	0.00528	0.0127	CcSEcCtD
Penbutolol—HTR1A—nervous system—multiple sclerosis	0.00508	0.0104	CbGeAlD
Penbutolol—HTR1A—central nervous system—multiple sclerosis	0.00489	0.00997	CbGeAlD
Penbutolol—HTR1B—brain—multiple sclerosis	0.00481	0.00981	CbGeAlD
Penbutolol—HTR1A—cerebellum—multiple sclerosis	0.00478	0.00974	CbGeAlD
Penbutolol—ADRB1—brain—multiple sclerosis	0.00452	0.00923	CbGeAlD
Penbutolol—Asthenia—Fingolimod—multiple sclerosis	0.0044	0.0106	CcSEcCtD
Penbutolol—Alopecia—Cladribine—multiple sclerosis	0.00432	0.0104	CcSEcCtD
Penbutolol—Diarrhoea—Fingolimod—multiple sclerosis	0.00419	0.0101	CcSEcCtD
Penbutolol—Agranulocytosis—Azathioprine—multiple sclerosis	0.00413	0.00996	CcSEcCtD
Penbutolol—Dizziness—Fingolimod—multiple sclerosis	0.00405	0.00977	CcSEcCtD
Penbutolol—HTR1A—brain—multiple sclerosis	0.00388	0.00791	CbGeAlD
Penbutolol—Headache—Fingolimod—multiple sclerosis	0.00384	0.00925	CcSEcCtD
Penbutolol—Affect lability—Prednisolone—multiple sclerosis	0.00375	0.00904	CcSEcCtD
Penbutolol—Upper respiratory tract infection—Mitoxantrone—multiple sclerosis	0.00373	0.009	CcSEcCtD
Penbutolol—Amnesia—Methylprednisolone—multiple sclerosis	0.00372	0.00897	CcSEcCtD
Penbutolol—Cough—Cladribine—multiple sclerosis	0.00372	0.00895	CcSEcCtD
Penbutolol—Erectile dysfunction—Mitoxantrone—multiple sclerosis	0.0037	0.00891	CcSEcCtD
Penbutolol—Mood swings—Prednisolone—multiple sclerosis	0.00361	0.0087	CcSEcCtD
Penbutolol—Alopecia—Azathioprine—multiple sclerosis	0.00351	0.00847	CcSEcCtD
Penbutolol—Affect lability—Triamcinolone—multiple sclerosis	0.00345	0.00832	CcSEcCtD
Penbutolol—Affect lability—Methylprednisolone—multiple sclerosis	0.00344	0.0083	CcSEcCtD
Penbutolol—Sweating—Mitoxantrone—multiple sclerosis	0.00343	0.00827	CcSEcCtD
Penbutolol—Hyperhidrosis—Cladribine—multiple sclerosis	0.00336	0.00809	CcSEcCtD
Penbutolol—Agranulocytosis—Mitoxantrone—multiple sclerosis	0.00334	0.00805	CcSEcCtD
Penbutolol—Mood swings—Triamcinolone—multiple sclerosis	0.00332	0.008	CcSEcCtD
Penbutolol—Mood swings—Methylprednisolone—multiple sclerosis	0.00331	0.00799	CcSEcCtD
Penbutolol—Bradycardia—Mitoxantrone—multiple sclerosis	0.00327	0.00789	CcSEcCtD
Penbutolol—Insomnia—Cladribine—multiple sclerosis	0.00314	0.00757	CcSEcCtD
Penbutolol—Affect lability—Dexamethasone—multiple sclerosis	0.00313	0.00755	CcSEcCtD
Penbutolol—Affect lability—Betamethasone—multiple sclerosis	0.00313	0.00755	CcSEcCtD
Penbutolol—Dyspnoea—Cladribine—multiple sclerosis	0.0031	0.00747	CcSEcCtD
Penbutolol—Mood swings—Dexamethasone—multiple sclerosis	0.00301	0.00726	CcSEcCtD
Penbutolol—Mood swings—Betamethasone—multiple sclerosis	0.00301	0.00726	CcSEcCtD
Penbutolol—Fatigue—Cladribine—multiple sclerosis	0.003	0.00722	CcSEcCtD
Penbutolol—Pain—Cladribine—multiple sclerosis	0.00297	0.00716	CcSEcCtD
Penbutolol—Amnesia—Prednisone—multiple sclerosis	0.00295	0.00711	CcSEcCtD
Penbutolol—Alopecia—Mitoxantrone—multiple sclerosis	0.00284	0.00685	CcSEcCtD
Penbutolol—Upper respiratory tract infection—Triamcinolone—multiple sclerosis	0.00282	0.00679	CcSEcCtD
Penbutolol—Body temperature increased—Cladribine—multiple sclerosis	0.00275	0.00662	CcSEcCtD
Penbutolol—Affect lability—Prednisone—multiple sclerosis	0.00273	0.00657	CcSEcCtD
Penbutolol—Bradycardia—Prednisolone—multiple sclerosis	0.00269	0.00647	CcSEcCtD
Penbutolol—Mood swings—Prednisone—multiple sclerosis	0.00262	0.00632	CcSEcCtD
Penbutolol—Sweating—Methylprednisolone—multiple sclerosis	0.00258	0.00623	CcSEcCtD
Penbutolol—Asthenia—Cladribine—multiple sclerosis	0.00249	0.00601	CcSEcCtD
Penbutolol—Bradycardia—Triamcinolone—multiple sclerosis	0.00247	0.00595	CcSEcCtD
Penbutolol—Bradycardia—Methylprednisolone—multiple sclerosis	0.00246	0.00594	CcSEcCtD
Penbutolol—Cough—Mitoxantrone—multiple sclerosis	0.00244	0.00588	CcSEcCtD
Penbutolol—Diarrhoea—Cladribine—multiple sclerosis	0.00238	0.00573	CcSEcCtD
Penbutolol—Dizziness—Cladribine—multiple sclerosis	0.0023	0.00554	CcSEcCtD
Penbutolol—Bradycardia—Dexamethasone—multiple sclerosis	0.00224	0.0054	CcSEcCtD
Penbutolol—Bradycardia—Betamethasone—multiple sclerosis	0.00224	0.0054	CcSEcCtD
Penbutolol—Body temperature increased—Azathioprine—multiple sclerosis	0.00223	0.00538	CcSEcCtD
Penbutolol—Hyperhidrosis—Mitoxantrone—multiple sclerosis	0.00221	0.00532	CcSEcCtD
Penbutolol—Erectile dysfunction—Prednisone—multiple sclerosis	0.00221	0.00531	CcSEcCtD
Penbutolol—Mood swings—Methotrexate—multiple sclerosis	0.00219	0.00529	CcSEcCtD
Penbutolol—Headache—Cladribine—multiple sclerosis	0.00218	0.00525	CcSEcCtD
Penbutolol—Depression—Prednisone—multiple sclerosis	0.00213	0.00513	CcSEcCtD
Penbutolol—Nausea—Cladribine—multiple sclerosis	0.00206	0.00497	CcSEcCtD
Penbutolol—Dyspnoea—Mitoxantrone—multiple sclerosis	0.00204	0.00491	CcSEcCtD
Penbutolol—Dyspepsia—Mitoxantrone—multiple sclerosis	0.00201	0.00484	CcSEcCtD
Penbutolol—Fatigue—Mitoxantrone—multiple sclerosis	0.00197	0.00475	CcSEcCtD
Penbutolol—Pain—Mitoxantrone—multiple sclerosis	0.00195	0.00471	CcSEcCtD
Penbutolol—Bradycardia—Prednisone—multiple sclerosis	0.00195	0.0047	CcSEcCtD
Penbutolol—Alopecia—Betamethasone—multiple sclerosis	0.00194	0.00469	CcSEcCtD
Penbutolol—Alopecia—Dexamethasone—multiple sclerosis	0.00194	0.00469	CcSEcCtD
Penbutolol—Diarrhoea—Azathioprine—multiple sclerosis	0.00193	0.00466	CcSEcCtD
Penbutolol—Dizziness—Azathioprine—multiple sclerosis	0.00187	0.0045	CcSEcCtD
Penbutolol—Upper respiratory tract infection—Methotrexate—multiple sclerosis	0.00186	0.00448	CcSEcCtD
Penbutolol—Erectile dysfunction—Methotrexate—multiple sclerosis	0.00184	0.00444	CcSEcCtD
Penbutolol—Cough—Triamcinolone—multiple sclerosis	0.00184	0.00444	CcSEcCtD
Penbutolol—Hyperhidrosis—Prednisolone—multiple sclerosis	0.00181	0.00437	CcSEcCtD
Penbutolol—Body temperature increased—Mitoxantrone—multiple sclerosis	0.00181	0.00435	CcSEcCtD
Penbutolol—Depression—Methotrexate—multiple sclerosis	0.00178	0.00429	CcSEcCtD
Penbutolol—Headache—Azathioprine—multiple sclerosis	0.00177	0.00427	CcSEcCtD
Penbutolol—Sweating—Methotrexate—multiple sclerosis	0.00171	0.00412	CcSEcCtD
Penbutolol—Insomnia—Prednisolone—multiple sclerosis	0.00169	0.00408	CcSEcCtD
Penbutolol—Alopecia—Prednisone—multiple sclerosis	0.00169	0.00408	CcSEcCtD
Penbutolol—Nausea—Azathioprine—multiple sclerosis	0.00168	0.00404	CcSEcCtD
Penbutolol—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.00167	0.00401	CcSEcCtD
Penbutolol—Agranulocytosis—Methotrexate—multiple sclerosis	0.00167	0.00401	CcSEcCtD
Penbutolol—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.00166	0.00401	CcSEcCtD
Penbutolol—Asthenia—Mitoxantrone—multiple sclerosis	0.00164	0.00395	CcSEcCtD
Penbutolol—Pain—Prednisolone—multiple sclerosis	0.0016	0.00386	CcSEcCtD
Penbutolol—Diarrhoea—Mitoxantrone—multiple sclerosis	0.00156	0.00377	CcSEcCtD
Penbutolol—Insomnia—Triamcinolone—multiple sclerosis	0.00156	0.00376	CcSEcCtD
Penbutolol—Insomnia—Methylprednisolone—multiple sclerosis	0.00156	0.00375	CcSEcCtD
Penbutolol—Dyspnoea—Triamcinolone—multiple sclerosis	0.00154	0.0037	CcSEcCtD
Penbutolol—Dyspepsia—Triamcinolone—multiple sclerosis	0.00152	0.00366	CcSEcCtD
Penbutolol—Dyspepsia—Methylprednisolone—multiple sclerosis	0.00151	0.00365	CcSEcCtD
Penbutolol—Hyperhidrosis—Betamethasone—multiple sclerosis	0.00151	0.00364	CcSEcCtD
Penbutolol—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.00151	0.00364	CcSEcCtD
Penbutolol—Fatigue—Triamcinolone—multiple sclerosis	0.00149	0.00358	CcSEcCtD
Penbutolol—Fatigue—Methylprednisolone—multiple sclerosis	0.00148	0.00357	CcSEcCtD
Penbutolol—Pain—Triamcinolone—multiple sclerosis	0.00147	0.00355	CcSEcCtD
Penbutolol—Headache—Mitoxantrone—multiple sclerosis	0.00143	0.00345	CcSEcCtD
Penbutolol—Alopecia—Methotrexate—multiple sclerosis	0.00142	0.00341	CcSEcCtD
Penbutolol—Insomnia—Betamethasone—multiple sclerosis	0.00141	0.00341	CcSEcCtD
Penbutolol—Insomnia—Dexamethasone—multiple sclerosis	0.00141	0.00341	CcSEcCtD
Penbutolol—Dyspepsia—Dexamethasone—multiple sclerosis	0.00138	0.00332	CcSEcCtD
Penbutolol—Dyspepsia—Betamethasone—multiple sclerosis	0.00138	0.00332	CcSEcCtD
Penbutolol—Body temperature increased—Triamcinolone—multiple sclerosis	0.00136	0.00328	CcSEcCtD
Penbutolol—Nausea—Mitoxantrone—multiple sclerosis	0.00136	0.00327	CcSEcCtD
Penbutolol—Fatigue—Dexamethasone—multiple sclerosis	0.00135	0.00325	CcSEcCtD
Penbutolol—Fatigue—Betamethasone—multiple sclerosis	0.00135	0.00325	CcSEcCtD
Penbutolol—Pain—Dexamethasone—multiple sclerosis	0.00134	0.00322	CcSEcCtD
Penbutolol—Pain—Betamethasone—multiple sclerosis	0.00134	0.00322	CcSEcCtD
Penbutolol—Hyperhidrosis—Prednisone—multiple sclerosis	0.00132	0.00317	CcSEcCtD
Penbutolol—Dizziness—Prednisolone—multiple sclerosis	0.00124	0.00299	CcSEcCtD
Penbutolol—Asthenia—Triamcinolone—multiple sclerosis	0.00124	0.00298	CcSEcCtD
Penbutolol—Body temperature increased—Dexamethasone—multiple sclerosis	0.00124	0.00298	CcSEcCtD
Penbutolol—Body temperature increased—Betamethasone—multiple sclerosis	0.00124	0.00298	CcSEcCtD
Penbutolol—Asthenia—Methylprednisolone—multiple sclerosis	0.00123	0.00297	CcSEcCtD
Penbutolol—Insomnia—Prednisone—multiple sclerosis	0.00123	0.00297	CcSEcCtD
Penbutolol—Cough—Methotrexate—multiple sclerosis	0.00122	0.00293	CcSEcCtD
Penbutolol—Dyspepsia—Prednisone—multiple sclerosis	0.0012	0.00289	CcSEcCtD
Penbutolol—Diarrhoea—Methylprednisolone—multiple sclerosis	0.00118	0.00283	CcSEcCtD
Penbutolol—Fatigue—Prednisone—multiple sclerosis	0.00117	0.00283	CcSEcCtD
Penbutolol—Headache—Prednisolone—multiple sclerosis	0.00117	0.00283	CcSEcCtD
Penbutolol—Dizziness—Triamcinolone—multiple sclerosis	0.00114	0.00275	CcSEcCtD
Penbutolol—Dizziness—Methylprednisolone—multiple sclerosis	0.00114	0.00274	CcSEcCtD
Penbutolol—Asthenia—Dexamethasone—multiple sclerosis	0.00112	0.0027	CcSEcCtD
Penbutolol—Asthenia—Betamethasone—multiple sclerosis	0.00112	0.0027	CcSEcCtD
Penbutolol—Nausea—Prednisolone—multiple sclerosis	0.00111	0.00268	CcSEcCtD
Penbutolol—Hyperhidrosis—Methotrexate—multiple sclerosis	0.0011	0.00265	CcSEcCtD
Penbutolol—Headache—Triamcinolone—multiple sclerosis	0.00108	0.0026	CcSEcCtD
Penbutolol—Headache—Methylprednisolone—multiple sclerosis	0.00108	0.0026	CcSEcCtD
Penbutolol—Body temperature increased—Prednisone—multiple sclerosis	0.00108	0.00259	CcSEcCtD
Penbutolol—Diarrhoea—Dexamethasone—multiple sclerosis	0.00107	0.00258	CcSEcCtD
Penbutolol—Diarrhoea—Betamethasone—multiple sclerosis	0.00107	0.00258	CcSEcCtD
Penbutolol—Dizziness—Betamethasone—multiple sclerosis	0.00103	0.00249	CcSEcCtD
Penbutolol—Dizziness—Dexamethasone—multiple sclerosis	0.00103	0.00249	CcSEcCtD
Penbutolol—Insomnia—Methotrexate—multiple sclerosis	0.00103	0.00248	CcSEcCtD
Penbutolol—Nausea—Triamcinolone—multiple sclerosis	0.00102	0.00247	CcSEcCtD
Penbutolol—Nausea—Methylprednisolone—multiple sclerosis	0.00102	0.00246	CcSEcCtD
Penbutolol—Dyspnoea—Methotrexate—multiple sclerosis	0.00101	0.00244	CcSEcCtD
Penbutolol—Dyspepsia—Methotrexate—multiple sclerosis	0.001	0.00241	CcSEcCtD
Penbutolol—Fatigue—Methotrexate—multiple sclerosis	0.000981	0.00236	CcSEcCtD
Penbutolol—Headache—Betamethasone—multiple sclerosis	0.00098	0.00236	CcSEcCtD
Penbutolol—Headache—Dexamethasone—multiple sclerosis	0.00098	0.00236	CcSEcCtD
Penbutolol—Asthenia—Prednisone—multiple sclerosis	0.000977	0.00235	CcSEcCtD
Penbutolol—Pain—Methotrexate—multiple sclerosis	0.000973	0.00235	CcSEcCtD
Penbutolol—Diarrhoea—Prednisone—multiple sclerosis	0.000932	0.00225	CcSEcCtD
Penbutolol—Nausea—Betamethasone—multiple sclerosis	0.000929	0.00224	CcSEcCtD
Penbutolol—Nausea—Dexamethasone—multiple sclerosis	0.000929	0.00224	CcSEcCtD
Penbutolol—Dizziness—Prednisone—multiple sclerosis	0.0009	0.00217	CcSEcCtD
Penbutolol—Body temperature increased—Methotrexate—multiple sclerosis	0.0009	0.00217	CcSEcCtD
Penbutolol—Headache—Prednisone—multiple sclerosis	0.000853	0.00206	CcSEcCtD
Penbutolol—Asthenia—Methotrexate—multiple sclerosis	0.000816	0.00197	CcSEcCtD
Penbutolol—Nausea—Prednisone—multiple sclerosis	0.000809	0.00195	CcSEcCtD
Penbutolol—Diarrhoea—Methotrexate—multiple sclerosis	0.000779	0.00188	CcSEcCtD
Penbutolol—Dizziness—Methotrexate—multiple sclerosis	0.000753	0.00181	CcSEcCtD
Penbutolol—Headache—Methotrexate—multiple sclerosis	0.000713	0.00172	CcSEcCtD
Penbutolol—Nausea—Methotrexate—multiple sclerosis	0.000676	0.00163	CcSEcCtD
Penbutolol—ADRB2—Signaling by GPCR—CXCL13—multiple sclerosis	0.00017	0.0018	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—CCR1—multiple sclerosis	0.000167	0.00176	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—CXCL13—multiple sclerosis	0.000167	0.00176	CbGpPWpGaD
Penbutolol—HTR1B—GPCR downstream signaling—PTGER4—multiple sclerosis	0.000165	0.00174	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—TAGAP—multiple sclerosis	0.00016	0.00168	CbGpPWpGaD
Penbutolol—HTR1B—GPCR downstream signaling—CXCR3—multiple sclerosis	0.00016	0.00168	CbGpPWpGaD
Penbutolol—ADRB1—GPCR ligand binding—CCL5—multiple sclerosis	0.000156	0.00165	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—TAGAP—multiple sclerosis	0.000156	0.00165	CbGpPWpGaD
Penbutolol—HTR1B—Signaling by GPCR—CCL3—multiple sclerosis	0.000156	0.00164	CbGpPWpGaD
Penbutolol—HTR1B—GPCR downstream signaling—CCR2—multiple sclerosis	0.000155	0.00164	CbGpPWpGaD
Penbutolol—ADRB2—GPCR ligand binding—CCL5—multiple sclerosis	0.000153	0.00161	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—TAGAP—multiple sclerosis	0.000153	0.00161	CbGpPWpGaD
Penbutolol—HTR1B—Signaling by GPCR—PTGER4—multiple sclerosis	0.00015	0.00158	CbGpPWpGaD
Penbutolol—HTR1A—GPCR ligand binding—CCL5—multiple sclerosis	0.00015	0.00158	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—RGS1—multiple sclerosis	0.000149	0.00157	CbGpPWpGaD
Penbutolol—HTR1B—Signaling by GPCR—CXCR3—multiple sclerosis	0.000145	0.00153	CbGpPWpGaD
Penbutolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	0.000145	0.00153	CbGpPWpGaD
Penbutolol—HTR1B—GPCR downstream signaling—CNR1—multiple sclerosis	0.000143	0.00151	CbGpPWpGaD
Penbutolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	0.000142	0.00149	CbGpPWpGaD
Penbutolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	0.000141	0.00149	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—GPR65—multiple sclerosis	0.000141	0.00149	CbGpPWpGaD
Penbutolol—ADRB1—GPCR ligand binding—CCR5—multiple sclerosis	0.000141	0.00149	CbGpPWpGaD
Penbutolol—HTR1B—Signaling by GPCR—CCR2—multiple sclerosis	0.000141	0.00149	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—S1PR1—multiple sclerosis	0.00014	0.00147	CbGpPWpGaD
Penbutolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	0.000138	0.00146	CbGpPWpGaD
Penbutolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	0.000138	0.00146	CbGpPWpGaD
Penbutolol—HTR1B—GPCR ligand binding—POMC—multiple sclerosis	0.000138	0.00146	CbGpPWpGaD
Penbutolol—ADRB2—GPCR ligand binding—CCR5—multiple sclerosis	0.000138	0.00145	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—S1PR1—multiple sclerosis	0.000137	0.00144	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—GPC5—multiple sclerosis	0.000136	0.00143	CbGpPWpGaD
Penbutolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	0.000135	0.00143	CbGpPWpGaD
Penbutolol—HTR1B—GPCR ligand binding—CCL2—multiple sclerosis	0.000135	0.00143	CbGpPWpGaD
Penbutolol—HTR1A—GPCR ligand binding—CCR5—multiple sclerosis	0.000135	0.00142	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—S1PR1—multiple sclerosis	0.000134	0.00141	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—GPC5—multiple sclerosis	0.000133	0.0014	CbGpPWpGaD
Penbutolol—ADRB1—GPCR downstream signaling—PTGER4—multiple sclerosis	0.000132	0.00139	CbGpPWpGaD
Penbutolol—HTR1B—Signaling by GPCR—CNR1—multiple sclerosis	0.00013	0.00137	CbGpPWpGaD
Penbutolol—HTR1A—SIDS Susceptibility Pathways—TNF—multiple sclerosis	0.00013	0.00137	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—GPC5—multiple sclerosis	0.00013	0.00137	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—CCR1—multiple sclerosis	0.000129	0.00136	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—CXCL13—multiple sclerosis	0.000129	0.00136	CbGpPWpGaD
Penbutolol—HTR1B—GPCR downstream signaling—CXCL10—multiple sclerosis	0.000129	0.00136	CbGpPWpGaD
Penbutolol—ADRB2—GPCR downstream signaling—PTGER4—multiple sclerosis	0.000129	0.00136	CbGpPWpGaD
Penbutolol—ADRB1—GPCR downstream signaling—CXCR3—multiple sclerosis	0.000127	0.00134	CbGpPWpGaD
Penbutolol—HTR1A—GPCR downstream signaling—PTGER4—multiple sclerosis	0.000126	0.00133	CbGpPWpGaD
Penbutolol—ADRB2—GPCR downstream signaling—CXCR3—multiple sclerosis	0.000124	0.00131	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—CCL3—multiple sclerosis	0.000124	0.00131	CbGpPWpGaD
Penbutolol—ADRB1—GPCR downstream signaling—CCR2—multiple sclerosis	0.000124	0.0013	CbGpPWpGaD
Penbutolol—HTR1A—GPCR downstream signaling—CXCR3—multiple sclerosis	0.000122	0.00128	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—CCL3—multiple sclerosis	0.000121	0.00128	CbGpPWpGaD
Penbutolol—ADRB2—GPCR downstream signaling—CCR2—multiple sclerosis	0.000121	0.00128	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—PTGER4—multiple sclerosis	0.000119	0.00126	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—CCL3—multiple sclerosis	0.000119	0.00125	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—RGS1—multiple sclerosis	0.000119	0.00125	CbGpPWpGaD
Penbutolol—HTR1A—GPCR downstream signaling—CCR2—multiple sclerosis	0.000118	0.00125	CbGpPWpGaD
Penbutolol—HTR1B—Signaling by GPCR—CXCL10—multiple sclerosis	0.000117	0.00124	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—PTGER4—multiple sclerosis	0.000117	0.00123	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—RGS1—multiple sclerosis	0.000116	0.00123	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—CXCR3—multiple sclerosis	0.000115	0.00122	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—PTGER4—multiple sclerosis	0.000114	0.00121	CbGpPWpGaD
Penbutolol—ADRB1—GPCR downstream signaling—CNR1—multiple sclerosis	0.000114	0.0012	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—RGS1—multiple sclerosis	0.000114	0.0012	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—CXCR3—multiple sclerosis	0.000113	0.00119	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—GPR65—multiple sclerosis	0.000113	0.00119	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—CCR2—multiple sclerosis	0.000112	0.00118	CbGpPWpGaD
Penbutolol—ADRB2—GPCR downstream signaling—CNR1—multiple sclerosis	0.000112	0.00118	CbGpPWpGaD
Penbutolol—HTR1B—GPCR downstream signaling—CCL5—multiple sclerosis	0.000111	0.00117	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—CXCR3—multiple sclerosis	0.00011	0.00116	CbGpPWpGaD
Penbutolol—ADRB1—GPCR ligand binding—POMC—multiple sclerosis	0.00011	0.00116	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—GPR65—multiple sclerosis	0.00011	0.00116	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—CCR2—multiple sclerosis	0.00011	0.00116	CbGpPWpGaD
Penbutolol—HTR1A—GPCR downstream signaling—CNR1—multiple sclerosis	0.000109	0.00115	CbGpPWpGaD
Penbutolol—ADRB1—GPCR ligand binding—CCL2—multiple sclerosis	0.000108	0.00114	CbGpPWpGaD
Penbutolol—ADRB2—GPCR ligand binding—POMC—multiple sclerosis	0.000108	0.00114	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—GPR65—multiple sclerosis	0.000108	0.00114	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—CCR2—multiple sclerosis	0.000107	0.00113	CbGpPWpGaD
Penbutolol—ADRB2—GPCR ligand binding—CCL2—multiple sclerosis	0.000105	0.00111	CbGpPWpGaD
Penbutolol—HTR1A—GPCR ligand binding—POMC—multiple sclerosis	0.000105	0.00111	CbGpPWpGaD
Penbutolol—HTR1A—SIDS Susceptibility Pathways—IL6—multiple sclerosis	0.000105	0.00111	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—CNR1—multiple sclerosis	0.000104	0.00109	CbGpPWpGaD
Penbutolol—HTR1A—GPCR ligand binding—CCL2—multiple sclerosis	0.000103	0.00109	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—CXCL13—multiple sclerosis	0.000103	0.00109	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—CCR1—multiple sclerosis	0.000103	0.00109	CbGpPWpGaD
Penbutolol—ADRB1—GPCR downstream signaling—CXCL10—multiple sclerosis	0.000103	0.00108	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—CNR1—multiple sclerosis	0.000101	0.00107	CbGpPWpGaD
Penbutolol—HTR1B—Signaling by GPCR—CCL5—multiple sclerosis	0.000101	0.00106	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—CXCL13—multiple sclerosis	0.000101	0.00106	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—CCR1—multiple sclerosis	0.000101	0.00106	CbGpPWpGaD
Penbutolol—ADRB2—GPCR downstream signaling—CXCL10—multiple sclerosis	0.0001	0.00106	CbGpPWpGaD
Penbutolol—HTR1B—GPCR downstream signaling—CCR5—multiple sclerosis	0.0001	0.00106	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—CNR1—multiple sclerosis	9.91e-05	0.00105	CbGpPWpGaD
Penbutolol—HTR1B—GPCR downstream signaling—IL2RA—multiple sclerosis	9.86e-05	0.00104	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—CCR1—multiple sclerosis	9.84e-05	0.00104	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—CXCL13—multiple sclerosis	9.84e-05	0.00104	CbGpPWpGaD
Penbutolol—HTR1A—GPCR downstream signaling—CXCL10—multiple sclerosis	9.82e-05	0.00104	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—CXCL10—multiple sclerosis	9.33e-05	0.000984	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—CCL3—multiple sclerosis	9.21e-05	0.000971	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—CXCL10—multiple sclerosis	9.12e-05	0.000963	CbGpPWpGaD
Penbutolol—HTR1B—Signaling by GPCR—CCR5—multiple sclerosis	9.08e-05	0.000958	CbGpPWpGaD
Penbutolol—HTR1B—Signaling by GPCR—IL2RA—multiple sclerosis	8.95e-05	0.000944	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—CXCL10—multiple sclerosis	8.92e-05	0.000941	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—PTGER4—multiple sclerosis	8.86e-05	0.000935	CbGpPWpGaD
Penbutolol—ADRB1—GPCR downstream signaling—CCL5—multiple sclerosis	8.84e-05	0.000933	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—PGR—multiple sclerosis	8.73e-05	0.000921	CbGpPWpGaD
Penbutolol—ADRB2—GPCR downstream signaling—CCL5—multiple sclerosis	8.65e-05	0.000913	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—CXCR3—multiple sclerosis	8.56e-05	0.000903	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—CD28—multiple sclerosis	8.48e-05	0.000895	CbGpPWpGaD
Penbutolol—HTR1A—GPCR downstream signaling—CCL5—multiple sclerosis	8.46e-05	0.000892	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—CCR2—multiple sclerosis	8.33e-05	0.000879	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—CCL5—multiple sclerosis	8.03e-05	0.000847	CbGpPWpGaD
Penbutolol—ADRB1—GPCR downstream signaling—CCR5—multiple sclerosis	7.96e-05	0.00084	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—CCL5—multiple sclerosis	7.85e-05	0.000829	CbGpPWpGaD
Penbutolol—ADRB1—GPCR downstream signaling—IL2RA—multiple sclerosis	7.85e-05	0.000828	CbGpPWpGaD
Penbutolol—HTR1B—GPCR downstream signaling—POMC—multiple sclerosis	7.82e-05	0.000825	CbGpPWpGaD
Penbutolol—ADRB2—GPCR downstream signaling—CCR5—multiple sclerosis	7.79e-05	0.000822	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—CNR1—multiple sclerosis	7.68e-05	0.000811	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—CCL5—multiple sclerosis	7.68e-05	0.00081	CbGpPWpGaD
Penbutolol—ADRB2—GPCR downstream signaling—IL2RA—multiple sclerosis	7.68e-05	0.00081	CbGpPWpGaD
Penbutolol—HTR1A—GPCR downstream signaling—CCR5—multiple sclerosis	7.62e-05	0.000804	CbGpPWpGaD
Penbutolol—HTR1A—GPCR downstream signaling—IL2RA—multiple sclerosis	7.51e-05	0.000792	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—CCL3—multiple sclerosis	7.33e-05	0.000774	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—CCR5—multiple sclerosis	7.23e-05	0.000763	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—CCL3—multiple sclerosis	7.17e-05	0.000757	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—IL2RA—multiple sclerosis	7.13e-05	0.000752	CbGpPWpGaD
Penbutolol—HTR1B—Signaling by GPCR—POMC—multiple sclerosis	7.1e-05	0.000749	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—CCR5—multiple sclerosis	7.08e-05	0.000747	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—PTGER4—multiple sclerosis	7.06e-05	0.000745	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—CCL3—multiple sclerosis	7.01e-05	0.00074	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—IL2RA—multiple sclerosis	6.97e-05	0.000736	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—PGR—multiple sclerosis	6.95e-05	0.000733	CbGpPWpGaD
Penbutolol—HTR1B—Signaling by GPCR—CCL2—multiple sclerosis	6.94e-05	0.000733	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—CCR5—multiple sclerosis	6.92e-05	0.00073	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—CXCL10—multiple sclerosis	6.92e-05	0.00073	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—PTGER4—multiple sclerosis	6.9e-05	0.000729	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—IL2RA—multiple sclerosis	6.82e-05	0.00072	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—CXCR3—multiple sclerosis	6.82e-05	0.000719	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—PGR—multiple sclerosis	6.8e-05	0.000717	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—CD28—multiple sclerosis	6.75e-05	0.000713	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—PTGER4—multiple sclerosis	6.75e-05	0.000712	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—CXCR3—multiple sclerosis	6.67e-05	0.000704	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—PGR—multiple sclerosis	6.65e-05	0.000702	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—CCR2—multiple sclerosis	6.63e-05	0.0007	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—CD28—multiple sclerosis	6.61e-05	0.000697	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—CXCR3—multiple sclerosis	6.52e-05	0.000688	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—CCR2—multiple sclerosis	6.49e-05	0.000684	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—CD28—multiple sclerosis	6.46e-05	0.000682	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—CCR2—multiple sclerosis	6.34e-05	0.000669	CbGpPWpGaD
Penbutolol—HTR1B—Signaling by GPCR—TYK2—multiple sclerosis	6.31e-05	0.000665	CbGpPWpGaD
Penbutolol—ADRB1—GPCR downstream signaling—POMC—multiple sclerosis	6.22e-05	0.000657	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—CNR1—multiple sclerosis	6.12e-05	0.000646	CbGpPWpGaD
Penbutolol—ADRB2—GPCR downstream signaling—POMC—multiple sclerosis	6.09e-05	0.000643	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—CD86—multiple sclerosis	6.05e-05	0.000638	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—CNR1—multiple sclerosis	5.99e-05	0.000632	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—CCL5—multiple sclerosis	5.95e-05	0.000628	CbGpPWpGaD
Penbutolol—HTR1A—GPCR downstream signaling—POMC—multiple sclerosis	5.95e-05	0.000628	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—CNR1—multiple sclerosis	5.85e-05	0.000618	CbGpPWpGaD
Penbutolol—HTR1B—GPCR downstream signaling—IL2—multiple sclerosis	5.78e-05	0.00061	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—POMC—multiple sclerosis	5.65e-05	0.000597	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—CCL2—multiple sclerosis	5.53e-05	0.000584	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—POMC—multiple sclerosis	5.53e-05	0.000584	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—SPP1—multiple sclerosis	5.51e-05	0.000582	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—CXCL10—multiple sclerosis	5.51e-05	0.000581	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—CCL2—multiple sclerosis	5.41e-05	0.000571	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—POMC—multiple sclerosis	5.41e-05	0.000571	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—CXCL10—multiple sclerosis	5.39e-05	0.000569	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—CCR5—multiple sclerosis	5.36e-05	0.000566	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—CCL2—multiple sclerosis	5.29e-05	0.000558	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—IL2RA—multiple sclerosis	5.29e-05	0.000558	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—CXCL10—multiple sclerosis	5.27e-05	0.000556	CbGpPWpGaD
Penbutolol—HTR1B—Signaling by GPCR—IL2—multiple sclerosis	5.25e-05	0.000554	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—TYK2—multiple sclerosis	5.02e-05	0.00053	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—TYK2—multiple sclerosis	4.91e-05	0.000518	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—APOE—multiple sclerosis	4.88e-05	0.000515	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—CD86—multiple sclerosis	4.82e-05	0.000508	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—TYK2—multiple sclerosis	4.8e-05	0.000507	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—CCL5—multiple sclerosis	4.74e-05	0.0005	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—CD86—multiple sclerosis	4.71e-05	0.000497	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—CCL5—multiple sclerosis	4.64e-05	0.00049	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—CD86—multiple sclerosis	4.61e-05	0.000486	CbGpPWpGaD
Penbutolol—ADRB1—GPCR downstream signaling—IL2—multiple sclerosis	4.6e-05	0.000486	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—CCL5—multiple sclerosis	4.54e-05	0.000479	CbGpPWpGaD
Penbutolol—ADRB2—GPCR downstream signaling—IL2—multiple sclerosis	4.5e-05	0.000475	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—CD80—multiple sclerosis	4.41e-05	0.000466	CbGpPWpGaD
Penbutolol—HTR1A—GPCR downstream signaling—IL2—multiple sclerosis	4.4e-05	0.000464	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—SPP1—multiple sclerosis	4.39e-05	0.000463	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—SPP1—multiple sclerosis	4.3e-05	0.000453	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—CCR5—multiple sclerosis	4.27e-05	0.000451	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—IL2RA—multiple sclerosis	4.21e-05	0.000444	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—SPP1—multiple sclerosis	4.2e-05	0.000443	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—POMC—multiple sclerosis	4.19e-05	0.000442	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—CCR5—multiple sclerosis	4.18e-05	0.000441	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—IL2—multiple sclerosis	4.18e-05	0.000441	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—IL2RA—multiple sclerosis	4.12e-05	0.000435	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—CCL2—multiple sclerosis	4.1e-05	0.000433	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—IL2—multiple sclerosis	4.09e-05	0.000431	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—CCR5—multiple sclerosis	4.09e-05	0.000431	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—IL2RA—multiple sclerosis	4.03e-05	0.000425	CbGpPWpGaD
Penbutolol—HTR1B—Signaling by GPCR—MAPK1—multiple sclerosis	4.01e-05	0.000424	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—IL2—multiple sclerosis	4e-05	0.000422	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—APOE—multiple sclerosis	3.89e-05	0.00041	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—APOE—multiple sclerosis	3.8e-05	0.000401	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—TYK2—multiple sclerosis	3.73e-05	0.000393	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—APOE—multiple sclerosis	3.72e-05	0.000392	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—CD80—multiple sclerosis	3.51e-05	0.000371	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—CD80—multiple sclerosis	3.44e-05	0.000363	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—CD80—multiple sclerosis	3.36e-05	0.000355	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—POMC—multiple sclerosis	3.34e-05	0.000352	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—CCL2—multiple sclerosis	3.27e-05	0.000345	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—POMC—multiple sclerosis	3.27e-05	0.000345	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—MAPK1—multiple sclerosis	3.2e-05	0.000337	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—CCL2—multiple sclerosis	3.2e-05	0.000337	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—POMC—multiple sclerosis	3.19e-05	0.000337	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—MAPK1—multiple sclerosis	3.13e-05	0.00033	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—CCL2—multiple sclerosis	3.13e-05	0.00033	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—IL2—multiple sclerosis	3.1e-05	0.000327	CbGpPWpGaD
Penbutolol—HTR1B—Signaling by GPCR—IL6—multiple sclerosis	3.08e-05	0.000325	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—MAPK1—multiple sclerosis	3.06e-05	0.000323	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—TYK2—multiple sclerosis	2.97e-05	0.000313	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—MMP9—multiple sclerosis	2.93e-05	0.00031	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—TYK2—multiple sclerosis	2.9e-05	0.000306	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—TYK2—multiple sclerosis	2.84e-05	0.000299	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—STAT3—multiple sclerosis	2.61e-05	0.000275	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—IL2—multiple sclerosis	2.47e-05	0.000261	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—IL6—multiple sclerosis	2.46e-05	0.000259	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—MYC—multiple sclerosis	2.42e-05	0.000256	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—TGFB1—multiple sclerosis	2.42e-05	0.000255	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—IL2—multiple sclerosis	2.41e-05	0.000255	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—IL6—multiple sclerosis	2.4e-05	0.000254	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—MAPK1—multiple sclerosis	2.37e-05	0.00025	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—IL2—multiple sclerosis	2.36e-05	0.000249	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—IL6—multiple sclerosis	2.35e-05	0.000248	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—MMP9—multiple sclerosis	2.34e-05	0.000247	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—MMP9—multiple sclerosis	2.29e-05	0.000241	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—MMP9—multiple sclerosis	2.23e-05	0.000236	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—STAT3—multiple sclerosis	2.08e-05	0.000219	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—STAT3—multiple sclerosis	2.03e-05	0.000214	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—STAT3—multiple sclerosis	1.99e-05	0.00021	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—MYC—multiple sclerosis	1.93e-05	0.000204	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—TGFB1—multiple sclerosis	1.93e-05	0.000203	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—MAPK1—multiple sclerosis	1.89e-05	0.000199	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—MYC—multiple sclerosis	1.89e-05	0.000199	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—TGFB1—multiple sclerosis	1.88e-05	0.000199	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—MAPK1—multiple sclerosis	1.85e-05	0.000195	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—MYC—multiple sclerosis	1.85e-05	0.000195	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—TGFB1—multiple sclerosis	1.84e-05	0.000194	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—IL6—multiple sclerosis	1.82e-05	0.000192	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—MAPK1—multiple sclerosis	1.81e-05	0.000191	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—IL6—multiple sclerosis	1.45e-05	0.000153	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—IL6—multiple sclerosis	1.42e-05	0.00015	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—IL6—multiple sclerosis	1.39e-05	0.000146	CbGpPWpGaD
